Colloquium: Perspectives of healthcare professionals on the ethics of PGT for polygenic conditions (PGT-P)

Colloquium research group Community Genetics

Perspectives of healthcare professionals on the ethics of preimplantation genetic testing for polygenic conditions (PGT-P) - Maria Siermann (Centre for Biomedical Ethics and Law, KU Leuven, Belgium)

Recently, preimplantation genetic testing for polygenic conditions (PGT-P) has been developed and introduced commercially. PGT-P aims to use polygenic risk scores to screen embryos for the risk of developing polygenic disorders, e.g. diabetes, cancer or schizophrenia. PGT-P raises ethical concerns and guidance and regulation are lacking. We performed a qualitative in-depth interview study with healthcare professionals in the field of reproductive medicine and genetics in European and North-American countries to get insights into their perspectives on the ethics of PGT-P.

For more background information (but not the specific content of this colloquium), see
A review of normative documents on preimplantation genetic testing: Recommendations for PGT-P - ScienceDirect

Link: Microsoft Teams-vergadering

Deelnemen op uw computer of via de mobiele app

Klik hier om deel te nemen aan de vergadering

For more information about the organization of the colloquium, please contact us at:

Dr Carla van El | Senior Researcher
Section Community Genetics, Department of Human Genetics/ Amsterdam Public Health research institute
Location VUmc | Room G122 | Van der Boechorststraat 7, 1081BT Amsterdam
T: 0031 20 444 8867 | E: cg.vanel@amsterdamumc.nl
Present: Mondays
Carla van El — Amsterdam UMC - Vrije Universiteit Amsterdam (vumc.nl)
ORCID https://orcid.org/0000-0003-2201-2320